Sub Heading

Clinical Trials Details

A Phase 2 study of JNJ-90301900 with Chemoradiation and Durvalumab for Non-Small Cell Lung Cancer

IRB Protocol Number
90301900NSC2001

Clinical Trial Categories

  • Lung Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: 

Men or women, ages 18 and older, with stage III non-small cell lung cancer that have not had prior treatment.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.